Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two human myeloma cell lines,
KMS
-12-PE and
KMS
-12-BM, were established from a 64-year-old woman with a non-producing type of multiple myeloma. The
KMS
-12-PE line originated from the pleural effusion and the
KMS
-12-BM from the bone marrow. These two lines showed the same chromosome marker, t(11:14)(q13:q32). However, their phenotypes of surface markers differed from each other.
KMS
-12-BM cells were positive to CD20, CD38 and
PCA
-1. showing the plasmacytoid (immature plasma cell) stage of B-cell differentiation, while
KMS
-12-PE cells were positive to CD38 and
PCA
-1, but not to CD20, indicating the terminal differentiated stage of B-cells. As seen in the pleural effusion of the patient.
KMS
-12-PE cells ectopically produced a salivary type of amylase, but
KMS
-12-BM cells did not. Interestingly, the chromosome abnormality of del(1)(p22----pter) near the region of 1p21, where the amylase gene was assigned, was noticed in as many as 76% of
KMS
-12-PE cells.
...
PMID:Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). 247 9
Since 1980 five human myeloma cell lines, KMM-1,
KMS
-5,
KMS
-11,
KMS
-12-PE and
KMS
-12-BM, have been established in Kawasaki Medical School. Histologically, all the cell lines resembled plasma cells and were EBNA negative. KMM-1,
KMS
-11,
KMS
-12-PE and
KMS
-12-BM reacted with
PCA
-1, while KMM-1,
KMS
-12-PE and
KMS
-12-BM with CD38. KMM-1 and
KMS
-11 secreted immunoglobulins into culture medium. Karyologically, all the cell lines were abnormal. Only
KMS
-5 was tumorigenic when transplanted subcutaneously into nude mice.
...
PMID:[Establishment and characterization of five human myeloma cell lines]. 251 19
Five human myeloma cell lines, KMM-1,
KMS
-5,
KMS
-11,
KMS
-12-PE, and
KMS
-12-BM, have been established at Kawasaki Medical School since 1980. As the
KMS
-12-PE and
KMS
-12-BM lines were obtained from the same patient, these five cell lines have been derived from four patients with multiple myeloma. The five myeloma cell lines are stably growing at present in RPMI 1640 medium supplemented with 10% fetal bovine serum. They can also grow in a defined culture medium without serum. That these cell lines were human myeloma cells was confirmed by the following findings. Ultrastructurally, all five cell lines showed features characteristic of plasma cells. KMM-1 and
KMS
-11 cells secreted lambda and kappa chains into the culture medium, respectively, but the other cell lines produced no immunoglobulins. KMM-1 expressed cytoplasmic lambda antigen,
KMS
-5 showed cytoplasmic delta, and
KMS
-11 expressed surface kappa, whereas
KMS
-12-PE and
KMS
-12-BM cells showed no surface or cytoplasmic immunoglobulins. Regarding reaction with a monoclonal plasma cell antibody (
PCA
-1), four of the five lines were positive, the exception being
KMS
-5. Another monoclonal antibody (CD38), which also recognizes plasma cells, responded to KMM-1,
KMS
-12-PE, and KSM-12-BM.
KMS
-5 cells expressed acute lymphoblastic leukemia antigens (CALLA). These data suggest that such lines as KMM-1,
KMS
-11,
KMS
-12-PE, and
KMS
-12-BM represent later stages of B-cell differentiation, and that
KMS
-5 represents a relatively early stage of B-cell differentiation. All the cell lines lacked Epstein-Barr virus nuclear antigen, showed abnormal karyotypes of human origin, and differed from each other in the isozyme patterns examined. Only
KMS
-5 was tumorigenic when transplanted subcutaneously into nude mice.
...
PMID:Establishment of five human myeloma cell lines. 276 32